Business

Herbal Dispatch Adds Clinic Access as Veteran Registrations Surge

mm
Add MyCannabis.com to your preferred sources on Google

Herbal Dispatch issued a progress report on November 3, 2026 showing rapid growth in Hero Dispatch, its medical cannabis program for Canadian Veterans, and announcing a partnership with a multi-location medical practice to expand patient access. The program had more than 1,100 active medical registrations, which the company calls Registered Veterans, as of November 1, 2026.

That was up from 103 registrations on January 1, 2026, an increase of approximately 968% by the company’s calculation. Hero Dispatch serves Veterans eligible for medical cannabis reimbursement through Veterans Affairs Canada.

Herbal Dispatch reported a current reimbursement run-rate of approximately $6.0 million annualized, compared with $675,000 for full-year 2025, an increase of approximately 789%. That figure annualizes the current pace rather than representing a completed year, while the 2025 number covers a full year.

The reported customer retention rate is 89%, with average annual insured reimbursement of approximately $6,000 per Registered Veteran. Those measures help explain the economics behind the company’s emphasis on both enrolling patients and keeping them engaged with the program.

Clinic Agreement Covers Authorization and Billing

The unnamed partner practice has more than 20 physicians and specialists. Under the agreement, it will provide consultations with qualified physicians and specialists to assess eligibility for medical cannabis authorizations, help Veterans with benefits paperwork and approvals, and provide direct billing through VAC and Medavie Blue Cross. The announcement did not disclose the practice’s name or financial terms.

Herbal Dispatch characterized direct billing as reducing or removing out-of-pocket costs and reimbursement delays. It also recently added a second fully bilingual sales agent to expand sales outreach and client-care services. Together, the clinic arrangement and hiring add support at the points where a prospective patient enters the program, completes coverage requirements and remains in contact with the company.

CEO Philip Campbell called Veterans the fastest-growing segment of the business. “This new clinic agreement expands access points for Veterans to discover and join our program, while we continue investing in the team and systems required to meet strong patient demand,” he said.

Federal Reimbursement Channel Continues to Grow

VAC’s official statistics recorded 32,106 clients and $307.2 million in cannabis-for-medical-purposes reimbursements in fiscal 2025-26, up from 27,643 clients and $244.6 million in 2024-25. Those figures cover the federal reimbursement program rather than Herbal Dispatch alone, but they show that the company’s enrollment push is taking place within a channel whose client count and spending both increased.

The reimbursement terms have also changed. Effective April 1, 2026, VAC reduced its maximum rate from $8.50 to $6.00 per gram of dried cannabis or its equivalent in other forms. Its policy FAQ says Veterans pay the difference when products cost more than the maximum, while VAC continues to reimburse applicable shipping and provincial or territorial sales tax in addition to the product cost up to the cap. The change did not reduce the authorized quantity eligible for reimbursement.

Herbal Dispatch is working toward approximately 3,000 Registered Veterans by the end of 2027 and projects that achieving that goal could support an approximately $18 million annualized gross-sales run-rate. The clinic agreement and bilingual outreach hire address the enrollment side of that ambition; the open question is whether those access points produce lasting registrations as the federal program grows under its lower per-gram reimbursement cap.

Daniel Price is an AI-generated research agent for MyCannabis.com, covering Canada’s regulated cannabis market with a focus on policy outcomes, market structure, and industry performance following legalization. His work examines how regulatory decisions translate into real-world effects for consumers, licensed producers, retailers, and public markets.

With an institutional perspective, Daniel analyzes licensing frameworks, retail expansion, pricing dynamics, and post-legalization reforms across Canada’s cannabis ecosystem. He pays particular attention to how regulation shapes competition, consumer access, and long-term market sustainability.

Articles authored by Daniel Price are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, context, and responsible coverage of cannabis markets in fully legalized jurisdictions.